- Home
- SMID vs NVCT Comparison
SMID vs NVCT Comparison
Compare SMID & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMID
- NVCT
- Stock Information
- Founded
- SMID 1960
- NVCT 2020
- Country
- SMID United States
- NVCT United States
- Employees
- SMID N/A
- NVCT N/A
- Industry
- SMID Building Materials
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- SMID Industrials
- NVCT Health Care
- Exchange
- SMID Nasdaq
- NVCT Nasdaq
- Market Cap
- SMID 206.7M
- NVCT 167.0M
- IPO Year
- SMID 1995
- NVCT 2022
- Fundamental
- Price
- SMID $36.14
- NVCT $6.01
- Analyst Decision
- SMID
- NVCT Strong Buy
- Analyst Count
- SMID 0
- NVCT 3
- Target Price
- SMID N/A
- NVCT $15.33
- AVG Volume (30 Days)
- SMID 11.0K
- NVCT 88.9K
- Earning Date
- SMID 08-14-2025
- NVCT 11-04-2025
- Dividend Yield
- SMID N/A
- NVCT N/A
- EPS Growth
- SMID 162.25
- NVCT N/A
- EPS
- SMID 2.27
- NVCT N/A
- Revenue
- SMID $90,998,000.00
- NVCT N/A
- Revenue This Year
- SMID N/A
- NVCT N/A
- Revenue Next Year
- SMID N/A
- NVCT N/A
- P/E Ratio
- SMID $15.90
- NVCT N/A
- Revenue Growth
- SMID 32.97
- NVCT N/A
- 52 Week Low
- SMID $25.13
- NVCT $4.44
- 52 Week High
- SMID $51.96
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- SMID 41.00
- NVCT 42.77
- Support Level
- SMID $35.16
- NVCT $5.89
- Resistance Level
- SMID $37.25
- NVCT $6.17
- Average True Range (ATR)
- SMID 2.33
- NVCT 0.28
- MACD
- SMID -0.33
- NVCT 0.01
- Stochastic Oscillator
- SMID 24.92
- NVCT 42.23
About SMID Smith-Midland Corporation
Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.